We have also shown that low CD93, BLIMP-1, and previously that low CXCR4 expression [19] are associated with poorer survival in MM patients treated with Bz all of which point toward a loss of some components of PC maturation as a mechanism of Bz resistance. The gene discussed is PRDM1; the disease is Miyoshi myopathy.